Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen

Background: Most patients with non-small cell lung cancer (NSCLC) experience disease progression after first-line treatment. The efficacy and safety of the nab-paclitaxel (nab-PTX) and bevacizumab combination as the second or further line of treatment in patients with advanced NSCLC have not been re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cancer
Main Authors: Hao, Xuezhi, Zhu, Yixiang, Mu, Yuxin, Wang, Shouzheng, Li, Junling, Xing, Puyuan
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2020
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532494/
https://ncbi.nlm.nih.gov/pubmed/33033525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.47072
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker